BHLHE41 and cancer: Indeed, apoptotic regulators DEC1 and DEC2 repress CLOCK/BMAL-induced transactivation of the PER1 promoter and modulate the response to cisplatin in several types of cancers [45,46,47], including human eSCC cell lines [48,49].